1. Home
  2. CNTN vs FINW Comparison

CNTN vs FINW Comparison

Compare CNTN & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.03

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

Logo FinWise Bancorp

FINW

FinWise Bancorp

HOLD

Current Price

$13.75

Market Cap

194.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTN
FINW
Founded
2017
1999
Country
United States
United States
Employees
12
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
185.3M
194.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
CNTN
FINW
Price
$2.03
$13.75
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
677.0K
34.4K
Earning Date
05-13-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.51
EPS
N/A
0.20
Revenue
N/A
N/A
Revenue This Year
N/A
$160.48
Revenue Next Year
N/A
$35.27
P/E Ratio
N/A
$68.85
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$12.82
52 Week High
$5.27
$22.49

Technical Indicators

Market Signals
Indicator
CNTN
FINW
Relative Strength Index (RSI) 37.11 46.76
Support Level N/A $13.72
Resistance Level $3.80 $14.70
Average True Range (ATR) 0.17 0.64
MACD -0.02 -0.02
Stochastic Oscillator 21.74 53.52

Price Performance

Historical Comparison
CNTN
FINW

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About FINW FinWise Bancorp

FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.

Share on Social Networks: